Cytomegalovirus Meningoencephalitis After Rituximab Treatment for Primary Central Nervous System Lymphoma
Marina P. Siakantaris(National and Kapodistrian University of Athens), George Vaiopoulos, John Tsonis(National and Kapodistrian University of Athens), Gerassimos A. Pangalis(Athens Medical Center), George Tzeletas(National and Kapodistrian University of Athens), Konstantina G. Yiannopoulou(Laiko General Hospital of Athens), Savvas Ioannou(Centre for Advanced Study), Vasiliki Papadopoulou(National and Kapodistrian University of Athens), Kimon V. Argyropoulos(Memorial Sloan Kettering Cancer Center), Aglaia Dimitrakopoulou
Cited by 8
Related Papers
Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia
|New England Journal of Medicine|2015|937
Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity
|Nature Medicine|2017|222
Clonal architecture of <i><scp>CXCR</scp>4 </i><scp>WHIM</scp>‐like mutations in Waldenström Macroglobulinaemia
|British Journal of Haematology|2015|142
Clinical approach to lymphadenopathy.
|PubMed|1993|93
Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients
|Annals of Hematology|2001|87